GD3 peptide mimics

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S327000

Reexamination Certificate

active

06998237

ABSTRACT:
The present invention provides peptide mimics for GD3 ganglioside. The peptide mimics were identified by panning phage display peptide libraries with an anti-GD3 monoclonal antibody. The peptide mimics inhibit the binding of an anti-GD3 antibody to GD3 positive cells and also elicit antibodies which can bind to GD3 positive cells. The identified peptide mimics can be used as immunogens for cancer therapy.

REFERENCES:
patent: 5807978 (1998-09-01), Kokolus et al.
patent: 5882654 (1999-03-01), Morton
patent: 1279677 (2003-01-01), None
patent: WO 200038515 (2000-07-01), None
patent: WO 200181371 (2001-11-01), None
Willers et al. (Peptides 1999; 20: 1021-1026).
Chapman et al.,Vaccination with a Bivalent GM2and GD2Ganglioside Conjugate Vaccine: A Trial Comparing Doses of GD2-Keyhole, Clinical Cancer Research (Dec. 2000) vol. 6, pp. 4658-4662.
Grant et al.,Long Survival of Pateints with Small Cell Lung Cancer after Adjuvant Treatment with the Anti-Idiotypic Antibody BEC2 Plus Bacillus Calmette-Guérin, Clinical Cancer Research (Jun. 1999) vol. 5, pp. 1319-1323.
Lesinski et al.,A DNA Vaccine Encoding a Peptide Mimic of Streptococcus Pneumoniae Serotype 4 Capsular Polysaccharide Induces Specific Anti-Carbohydrate Antibodies in Balb/c Mice, Vaccine (2001) vol. 19, pp. 1717-1726.
Luo et al.,A Molecular Basis for Functional Peptide Mimicry of a Carbohydrate Antigen, The Journal of Biological Chemistry (May 26, 2000) vol. 275, No. 21, pp. 16146-16154.
McCaffery et al.,Immunization of Melanoma Patients with BEC2 Anti-Idiotypic Monoclonal Antibody That Mimics GD3 Ganglioside: Enhanced Immunogenicity WhenCombined with Adjuvant, Clinical Cancer Research (Apr. 1996) vol. 2, pp. 679-686.
Qiu et al.,Towards the Development of Peptide Mimotopes of Carbohydrate Antigens as Cancer Vaccines, Hybridoma (1999) vol. 18, No. 1, pp. 103-112.
Yao et al.,Immunization of Melanoma Patients with BEC2-Keyhole Limpet Hemocyanin Plus BCG Intradermally Followed by Intravenous Booster Immunizations with BEC2 to Induces Anti-GD3 Ganglioside Antibodies, Clinical Cancer Research (Jan. 1999) vol. 5, pp. 77-81.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

GD3 peptide mimics does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with GD3 peptide mimics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and GD3 peptide mimics will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3709695

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.